(Q46886348)

English

Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy.

scientific article published in January 2005

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16401959

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16401959%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 January 2020

title

Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16401959

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16401959%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

0 references

1 reference

Giedre Rutkauskiene

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16401959

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16401959%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 January 2020

Liutauras Labanauskas

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16401959

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16401959%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 January 2020

publication date

1 January 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16401959

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16401959%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

16401959

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16401959%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 January 2020

volume

41

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16401959

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16401959%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 January 2020

issue

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16401959

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16401959%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 January 2020

page(s)

1026-1034

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16401959

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16401959%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 January 2020

Identifiers

PubMed publication ID

16401959

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16401959

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16401959%20AND%20SRC:MED&resulttype=core&format=json

(Q46886348)

Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)